Jim Tananbaum has been the celebrated CEO of Foresite Capital since its founding in 2011. He architected the company as a leading healthcare dedicated private equity firm. Foresite specializes in identifying upcoming healthcare leaders, which it assists to grow to profitability by supplying networks, information, and capital. Jim has also co-founded biopharmaceutical companies such as Theravance, Inc., and GelTex
How Foresite Capital Started
Jim was interviewed by Ideamensch and revealed that he gained the idea of inaugurating Foresite Capital emerged from his broad experience of 25 years as an investment strategist and entrepreneur. He mentioned that the insight of the future healthcare emerged from recognizing that healthcare products often required significantly more capital and time. Therefore, the company plays a vital role in supplying emerging leaders with information, capital, and networks to help them become successful. Jim revealed that the company had currently invested in biopharmaceutical and medical services.
Personal Experiences of Jim Tananbaum
Jim cited that involving the effective and smartest leaders in the health industry was essential for coming up with helpful ideas in the health industry. He mentioned that the science behind healthcare innovation was the core of what he did and he was inspired by how entrepreneurs solved healthcare’s unmet requirements. Additionally, Jim cited that his passion for reading coupled with persistence and commitment have allowed him to continue building Foresite Capital and expand its innovative portfolio.
Jim Tananbaum is the acclaimed CEO and founder of Foresite Capital, a leading healthcare dedicated private equity firm. Foresite Capital specializes in recognizing emerging healthcare leaders, which it helps to grow to productivity through supplying them with networks, capital, and information. Before establishing the company, he had co-founded many companies, which have grown to become renowned healthcare franchises.
Jim Tananbaum was the co-founder and CEO of Geltex Pharmaceutical when he completed his business school. Seven years later, he founded Theravance, which invented GSK, a treatment for asthma. Jim has also participated in many financial ventures, for instance, he was a co-founder investor of HealtheonWebMD and Jazz Pharmaceuticals.
Jim was a student at Yale University where he undertook a math and electrical engineering/computer science major. He also obtained his MD from the same institution. Jim went to study at Harvard where he got an MBA and an MIS from MIT (Massachusetts Institute of Technology).
Check out his About.me
See more: https://ideamensch.com/jim-tananbaum/